Y. Abuodeh

发表

Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.

S. Eschrich, J. Torres-Roca, B. Yue, 2016, International journal of radiation oncology, biology, physics.

Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource Settings.

A. Naghavi, D. Fernandez, M. Echevarria, 2016, International journal of radiation oncology, biology, physics.

Postoperative Stereotactic Radiosurgery Using 5-Gy × 5 Sessions in the Management of Brain Metastases.

P. Johnstone, A. Naghavi, P. Venkat, 2016, World neurosurgery.

Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases

K. Ahmed, P. Chinnaiyan, N. Figura, 2014, Journal of Neuro-Oncology.

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy

A. Naghavi, P. Venkat, M. Echevarria, 2016, Journal of contemporary brachytherapy.

Kinetic analysis of contralateral liver hypertrophy after radioembolization of primary and metastatic liver tumors

A. Naghavi, S. Hoffe, D. Anaya, 2018, Surgery.

Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma

Jacob G. Scott, John E. Mullinax, T. Strom, 2017, Journal of contemporary brachytherapy.

Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma

L. Harrison, T. Robinson, A. Naghavi, 2017, Therapeutic advances in hematology.

Stage I seminoma: Treatment outcomes in a low-income country.

J. Khader, A. Salem, Y. Abuodeh, 2012, The Gulf journal of oncology.

Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan

J. Khader, A. Salem, Y. Abuodeh, 2012, BMC Urology.

Systematic review of case reports on the abscopal effect.

P. Venkat, Sungjune Kim, Y. Abuodeh, 2016, Current problems in cancer.

The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base

P. Johnstone, A. Naghavi, Y. Abuodeh, 2019, Cancer.

Management of Oropharyngeal Cancer in the HPV Era.

T. Strom, L. Harrison, A. Naghavi, 2016, Cancer control : journal of the Moffitt Cancer Center.

Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.

Jacob G. Scott, R. Gonzalez, M. Bui, 2016, Brachytherapy.

Breast and Soft Tissue Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma

Jacob G. Scott, R. Gonzalez, M. Bui, 2016 .

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.

L. Harrison, P. Johnstone, A. Naghavi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non–Small‐Cell Lung Cancer Patients

T. Dilling, A. Naghavi, B. Perez, 2019, Clinical lung cancer.

Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta‐analysis

C. Stevens, T. Dilling, V. Feygelman, 2018, Clinical lung cancer.

Patient choice for high‐volume center radiation impacts head and neck cancer outcome

T. Strom, C. Chung, L. Harrison, 2018, Cancer medicine.

Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies

T. Strom, L. Harrison, A. Naghavi, 2016, Cancer.

Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma.

M. Friedman, S. Hoffe, J. Sweeney, 2018, Journal of gastrointestinal oncology.

Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization

M. Malafa, A. Naghavi, S. Hoffe, 2016, World journal of gastroenterology.

Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer.

R. Shridhar, A. Naghavi, S. Hoffe, 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Treatment delays, race, and outcomes in head and neck cancer.

T. Strom, L. Harrison, B. Green, 2016, Cancer epidemiology.

Race Is Associated With Poor Outcomes in Head and Neck Cancer

T. Strom, L. Harrison, B. Green, 2016 .

Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses

A. Naghavi, R. Wilder, Zhenjun Ma, 2017, International braz j urol : official journal of the Brazilian Society of Urology.

Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization.

A. Giuliano, R. Shridhar, M. Friedman, 2018, Journal of gastrointestinal oncology.

Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. In regard to van Loon et al. (Int J Radiat Oncol Biol Phys 2010;77:329-336).

J. Khader, A. Salem, Y. Abuodeh, 2010, International Journal of Radiation Oncology, Biology, Physics.

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.

L. Harrison, P. Johnstone, A. Naghavi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.

Jacob G. Scott, R. Gonzalez, M. Bui, 2016, Brachytherapy.